Records containing: Portopulmonary Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-30
Assessment of Cardiac Problems in Children With Chronic Liver Disease
CLINICAL_TRIALS study record update · 2026-01-20
Genetic Hallmarks of Patients With Congenital Portosystemic Shunts and Portopulmonary Hypertension
CLINICAL_TRIALS study record update · 2021-01-12
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
CLINICAL_TRIALS study record update · 2019-09-27
Revatio Portal-Pulmonary Arterial Hypertension Trial (RePo1 Trial): A Randomized, Double-blinded, Placebo-controlled, Multi-center Study to Evaluate the Effects of Sildenafil Citrate (Revatio) 20 mg TID on Patients With Portal Pulmonary Arterial Hypertension (PPAH)
CLINICAL_TRIALS study record update · 2018-12-07
Investigator Sponsored Research Proposal : Efficacy and Safety of Combination Ambrisentan and TadaLafil in PATiEnts With PortoPulmonary Hypertension (ESCALATE-PPH)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2018-11-23
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
CLINICAL_TRIALS study record update · 2017-02-24
An Open-Label Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
CLINICAL_TRIALS study record update · 2016-06-17
Ambrisentan for Treatment of Portopulmonary Hypertension (PoPH): a Pilot Study